Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evaporation Chemistry at ACS

Published: Monday, August 19, 2013
Last Updated: Monday, August 19, 2013
Bookmark and Share
Genevac to display its latest products for productive evaporation in USA.

Genevac has announced that it will display its latest products for productive evaporation at the 246th American Chemical Society meeting and exposition in Indianapolis, Indiana, USA (8th - 12th September 2013).Genevac_PN.gif

Visitors to Booth 2017 will have the chance to see for the first time the ROCKET 4D - a new fully automated system for drying or concentration of very large volumes (a few to 100 litres) in one operation with no user interaction.

Simply load sample, select a method, press start, and walk away - the system will do the rest.

Compact in size the ROCKET 4D allows users to safely dry or concentrate their samples with complete confidence as it uses proprietary vacuum technology to suppress solvent bumping and foaming - problems associated with sample loss when using large scale rotary evaporators.

To download a ROCKET 4D technical brochure, please visit www.genevac.com/Rocket4D.

Specialists will also be on hand to demonstrate and discuss the third generation EZ-2 Series Evaporator - an easy-to-use benchtop system that uses the most advanced proven technology in evaporation science.

The EZ-2 accurately controls vacuum and temperature to enable rapid evaporation of a wide range of solvents and prevent bumping and cross contamination.

Compatible with a wide range of sample holders the EZ-2 will easily integrate within the workflow of many laboratories. Options are available to enable routine, safe removal of potentially explosive solvents such as diethyl ether or pentane and also removal of acids including concentrated hydrochloric acid (HCl).

To download an EZ-2 technical brochure, watch a product video or download applications reports please visit - www.genevac.com/movie/ez2.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
Novavax RSV F Vaccine Fails Phase 3 Trial
Novavax announces topline RSV F Vaccine data from two clinical trials in older adults.
GSK’s Shingles Vaccine Candidate Shows High Efficacy
The vaccine candidate showed high efficacy against shingles and its complications in adults aged 70yrs+ in phase III study.
Eisai Establishes AiM Institute
The Andover innovative Medicines (AiM) Institute will develop innovative precision medicines for hard-to-treat conditions.
Antibodies that Target Holes in HIV's Defence Identified
Scientists suggest 'holes' in HIV sugar sheild can be targeted by antibodies.
Discovery Could Yield Improved Flu Vaccines
Researchers have discovered a type of immune antibody that can evolve to combat a number of infuenza virus strains.
First Accurate Simulation of a Virus Invading a Cell
For the first time, scientists know what happens to a virus’ shape when it invades a host cell.Understanding how the virus shape specifically changes could lead to more effective anti-viral therapies.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!